Minerva Surgical (Minerva Surgical) Ending Cash Position : $11.47 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Minerva Surgical Ending Cash Position?

Minerva Surgical's Ending Cash Position for the quarter that ended in Sep. 2023 was $11.47 Mil.

Minerva Surgical's quarterly Ending Cash Position declined from Mar. 2023 ($26.12 Mil) to Jun. 2023 ($16.58 Mil) and declined from Jun. 2023 ($16.58 Mil) to Sep. 2023 ($11.47 Mil).

Minerva Surgical's annual Ending Cash Position increased from Dec. 2020 ($25.17 Mil) to Dec. 2021 ($48.42 Mil) but then declined from Dec. 2021 ($48.42 Mil) to Dec. 2022 ($7.81 Mil).

Minerva Surgical Ending Cash Position Historical Data

The historical data trend for Minerva Surgical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minerva Surgical Ending Cash Position Chart

Minerva Surgical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

34.78

25.17

48.42

7.81

Minerva Surgical Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Ending Cash Position	Get a 7-Day Free Trial										23.40	7.81	26.12	16.58	11.47

Minerva Surgical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Minerva Surgical's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	48.415	+	-40.604
	=	7.81

Minerva Surgical's Ending Cash Position for the quarter that ended in Sep. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	16.582	+	-5.112
	=	11.47

Minerva Surgical Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Minerva Surgical's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Minerva Surgical (Minerva Surgical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Minerva Surgical Inc (OTCPK:UTRS) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

4255 Burton Drive, Santa Clara, CA, USA, 95054

Website

https://www.minervasurgical.com

Minerva Surgical Inc is a medical device company that develops therapeutic devices that treat abnormal uterine bleeding in a minimally invasive manner. The Company operates and manages its business as one reportable and operating segment, which is the business of research, development, and sale of therapeutic devices for abnormal uterine bleeding treatment.

Executives

Daniel Cohen	director	C/O ACCELMED, 848 BRICKELL AVE, #901, MIAMI FL 33131
Accelmed Partners Ii L.p.	10 percent owner	2875 NE 191ST, SUITE 500, AVENTURA FL 33180
New Enterprise Associates 13 Lp	10 percent owner	1119 ST PAUL STREET, BALTIMORE MD 21202
Uri Geiger	director, 10 percent owner	221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815
Todd Usen	director, officer: Chief Executive Officer	C/O MINERVA SURGICAL, INC., 4255 BURTON DRIVE, SANTA CLARA CA 95054
Derrick Sung	director	C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 380, SAN FRANCISCO CA 94103
David M Clapper	director, officer: President and CEO	3003 TASMAN DRIVE, SANTA CLARA CA 95054
Novo Holdings A/s	10 percent owner	TUBORG HAVNEVEJ 19, HELLERUP G7 2900
Jaffe Ross A Md	director	ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104
Evgueni V. Skalnyi	officer: VP Medical Affairs	C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054
Dominique J. Filloux	officer: COO	C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054
Joel R Jung	officer: CFO	1401 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Niquette L. Hunt	director	SOLITON, INC., 5304 ASHBROOK DRIVE, HOUSTON TX 77081
Jill Anderson	director	1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Nea Partners 13, Limited Partnership	10 percent owner	1119 ST. PAUL STREET, BALTIMORE MD 21202